Abstract:OBJECTIVES:With the decreased protective effect of Bacille Calmette-Guérin (BCG) vaccine, widespread drug-resistant strains of tuberculosis as well as the lack of effective vaccines, global morbidity and mortality of tuberculosis remains high. The purpose of this study is to evaluate the potential of Mycobacterium tuberculosis antigen Rv2654 as a candidate vaccine against tuberculosis, and to verify the characteristics of cellular and humoral immune responses in mice induced by this protein.METHODS:Isopropyl-beta-D-thiogalactoside (IPTG) was added to induce the expression of Rv2654 recombinant protein in the logarithmic growth stage of bacteria. The recombinant protein was purified by affinity chromatography and identified by Western blotting. The immunoreactivity of Rv2654 recombinant protein with human sera was detected by ELISA. After immunization with Rv2654 recombinant protein, the levels of Th1/Th2 cytokines in peripheral blood of mice was measured using cytokine magnetic bead arrays, and the T and B lymphocyte subsets in spleen of mice was analyzed by flow cytometry.RESULTS:The recombinant protein Rv2654 was successfully induced and expressed. The ELISA data showed that the recombinant protein Rv2654 was responsive to the serum of BCG-inoculated patients or active pulmonary tuberculosis patients. In immunized mice with recombinant protein Rv2654, the expression of IFN-γ, TNF-α, IL-2, IL-4, IL-6, IL-10 and other cytokines in peripheral blood was elevated (all P<0.05). Flow cytometry analysis showed that the recombinant protein significantly stimulated the differentiation of CD4+T cells and CD8+T cells into effector T cells, and this effect was more obvious when combined with BCG. The recombinant protein Rv2654 also stimulated the activation and proliferation of B cells and their differentiation into memory cells. However, less plasma cells were produced.CONCLUSIONS:Rv2654 protein could induce the cell immune responses and it has good binding ability with serum of BCG-inoculated patients and active pulmonary tuberculosis patients, suggesting that it may serve as a good candidate antigen for tuberculosis immunological prophylaxis and diagnostic vaccines.

Secreted Rv1768 From RD14 of Mycobacterium tuberculosis Activates Macrophages and Induces a Strong IFN-γ-Releasing of CD4 + T Cells.

Mycobacterial Rv1804c Binds to the PEST Domain of IκBα and Activates Macrophage-Mediated Proinflammatory Responses

Identification of a novel immunodominant antigen Rv2645 from RD13 with potential as a cell-mediated immunity-based TB diagnostic agent

Mycobacterium Tuberculosis Rv0426c Promotes Recombinant Mycobacteria Intracellular Survival Via Manipulating Host Inflammatory Cytokines and Suppressing Cell Apoptosis.

Expression and Purification of Rv2654 Recombinant Protein from Mycobacterium Tuberculosis and Its Characteristics of Immune Response.

The DosR Antigen Rv1737c from Mycobacterium Tuberculosis Confers Inflammation Regulation in Tuberculosis Infection

Mycobacterium tuberculosis Rv3435c regulates inflammatory cytokines and promotes the intracellular survival of recombinant Mycobacteria

Mycobacterium tuberculosis protein Rv2652c enhances intracellular survival by inhibiting host immune responses

Immunological evaluation of a novel Mycobacterium tuberculosis antigen, Rv3117, absent in Mycobacterium bovis BCG.

Recombinant Lipoprotein Rv1016c Derived from Mycobacterium Tuberculosis is a TLR-2 Ligand That Induces Macrophages Apoptosis and Inhibits MHC II Antigen Processing

Immunogenic profiling of Mycobacterium tuberculosis Rv1513 reveals its ability to switch on Th1 based immunity

Mycobacterium tuberculosis Rv0341 Promotes Mycobacterium Survival in In Vitro Hostile Environments and within Macrophages and Induces Cytokines Expression

Rv2820c of Beijing/W Strains Enhances Mycobacterium Tuberculosis Survival in Human Macrophages

High Immunogenicity of a T-Cell Epitope-Rich Recombinant Protein Rv1566c-444 From Mycobacterium tuberculosis in Immunized BALB/c Mice, Despite Its Low Diagnostic Sensitivity

DosR Antigen Rv1737c Induces Activation of Macrophages Dependent on the TLR2 Pathway.

Rv3722c Promotes Mycobacterium tuberculosis Survival in Macrophages by Interacting With TRAF3

Mycobacterium Tuberculosis Rv3402c Enhances Mycobacterial Survival Within Macrophages and Modulates the Host Pro-Inflammatory Cytokines Production Via NF-kappa B/ERK/p38 Signaling.

Mycobacterium Tuberculosis Rv1515c Antigen Enhances Survival of M. Smegmatis Within Macrophages by Disrupting the Host Defence.

Rv1985c, a promising novel antigen for diagnosis of tuberculosis infection from BCG-vaccinated controls

PPE Protein (rv3425) from DNA Segment RD11 of Mycobacterium Tuberculosis: a Novel Immunodominant Antigen of Mycobacterium Tuberculosis Induces Humoral and Cellular Immune Responses in Mice.

Recombinant protein Rv2346c inhibits the immunological response of macrophage against Mycobacterium tuberculosis